Biohaven's nurtec® odt signs as primary partner with rick ware racing for 2021 ntt indycar series program

Mooresville, n.c., may 14, 2021 /prnewswire/ -- biohaven pharmaceuticals (nyse:bhvn) announced today that nurtec® odt (rimegepant) will be the primary partner for the rick ware racing no.
BHVN Ratings Summary
BHVN Quant Ranking